Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
2000 Turkeys
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
2000 Turkeys
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
1,351.12
-31.63 (-2.29%)
Official Closing Price
Updated: 4:10 PM EST, Nov 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Retatrutide Research Draws Attention in Costa Rica as Demand for Reliable Scientific Information Grows
November 03, 2026
Via
Press Release Distribution Service
Phibro Animal Health (PAHC) reports earnings tomorrow: what to expect
November 02, 2026
Animal health products manufacturer Phibro Animal Health (NASDAQ:PAHC) will be announcing earnings results this Wednesday after market hours. Here’s what inv...
Via
StockStory
Eli Lilly Stock: Is It Still a Buy at $1,400?
↗
November 02, 2026
The company just released some incredible quarterly results, but its valuation is also fairly high.
Via
The Motley Fool
Eli Lilly Just Delivered Another Blowout Quarter. Is This Unstoppable Growth Stock Still a Buy?
↗
November 02, 2026
The drugmaker continues its impressive run.
Via
The Motley Fool
Eli Lilly (NYSE:LLY) Beats Q3 Estimates, Raises Guidance as Shares Jump
↗
October 29, 2026
Via
Chartmill
GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
↗
November 02, 2026
Compares the Roundhill GLP-1 & Weight Loss ETF (OZEM) and the newer REX Peptide ETF (PEPT), examining holdings, fees, and overlap as GLP-1 drug demand from Eli Lilly and Novo Nordisk continues to...
Via
MarketBeat
Topics
ETFs
Here's Why I Think Every Investor Needs to Invest in These "Miracle" Drugs
↗
November 02, 2026
The market for GLP-1 drugs is forecast to explode. It may be understated still.
Via
The Motley Fool
UBS Just Initiated Coverage of Viking Therapeutics With a Buy Rating and a $94 Target. Here's the Bull Case.
↗
November 02, 2026
Trial results for its weight loss drugs could justify a higher valuation for the clinical-stage biotech.
Via
The Motley Fool
Amneal (AMRX) Q3 earnings: what to expect
November 02, 2026
Pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) will be reporting results tomorrow before market hours. Here’s what to expect. Amneal beat analys...
Via
StockStory
What to expect from Pfizer’s (PFE) Q3 earnings
November 01, 2026
Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting results this Tuesday before market open. Here’s what to expect. Pfizer beat analysts’ reven...
Via
StockStory
Corcept (CORT) to report earnings tomorrow: here is what to expect
November 01, 2026
Biopharma company Corcept Therapeutics (NASDAQ:CORT) will be announcing earnings results this Tuesday after market hours. Here’s what to look for. Corcept be...
Via
StockStory
Topics
Artificial Intelligence
Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
↗
November 01, 2026
Eli Lilly posted 39% YOY revenue growth in Q3 2026 on strong Mounjaro and Zepbound sales, raising full-year guidance even as Medicare's GLP-1 Bridge program pressures drug pricing.
Via
MarketBeat
Novo Nordisk Trades at 10 Times Earnings While Buying Back Billions in Stock. Is This the Bottom?
↗
November 01, 2026
Novo Nordisk is shifting its business model, with 2026 likely to represent an inflection point.
Via
The Motley Fool
What to expect from Jazz Pharmaceuticals’s (JAZZ) Q3 earnings
October 31, 2026
Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) will be reporting results this Monday after market hours. Here’s what to expect. Jazz Pharmaceuticals be...
Via
StockStory
After Eli Lilly’s Explosive Earnings Report, Is It Too Late to Buy the Stock?
↗
October 31, 2026
Eli Lilly stock is trading at a record high.
Via
The Motley Fool
Topics
Earnings
Prediction: $100 per Month Invested in Eli Lilly (LLY) Stock Will Be Worth This Much by 2030
↗
October 31, 2026
GLP-1 weight loss drugs are propelling profits for some drugmakers like Eli Lilly.
Via
The Motley Fool
2 Stocks Billionaires Can't Stop Buying
↗
October 31, 2026
Should you buy these stocks, too?
Via
The Motley Fool
What Eli Lilly and Company (LLY) Said on Its Q3 Earnings Call
↗
October 30, 2026
Eli Lilly and Company (NYSE:LLY) raised its full-year outlook after reporting third-quarter revenue growth of 39% from the prior-year period, driven primarily by demand for its Mounjaro and Zepbound...
Via
MarketBeat
Topics
ETFs
Earnings
OmniAb (OABI) Q3 2026 Earnings Call Transcript
↗
October 30, 2026
Revenue jumped to $4M as xPloration expands and Lilly partnership unlocks $3B in milestones.
Via
The Motley Fool
Topics
Earnings
Eli Lilly Is Now Worth as Much as Warren Buffett's Berkshire Hathaway. Can the Rally Keep Going?
↗
October 30, 2026
Eli Lilly's business is heavily driven by one product, while Berkshire Hathaway is a diversified conglomerate.
Via
The Motley Fool
Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF
↗
October 30, 2026
VanEck's concentrated 26-stock portfolio delivered stronger five-year returns and lower volatility, while State Street's 62-holding fund offers broader diversification and lower fees.
Via
The Motley Fool
Topics
ETFs
Novo Has Big Plans for 2030. Should You Buy the Stock Now?
↗
October 29, 2026
The company’s comeback strategy looks sound.
Via
The Motley Fool
Eli Lilly (LLY) Q3 2026 Earnings Call Transcript
↗
October 29, 2026
Revenue surged 39% on blockbuster obesity drug demand and strong international growth.
Via
The Motley Fool
Topics
Earnings
S&P 500 Top Movers: Oct. 29, 2026 Gainers and Losers
↗
October 29, 2026
Via
Chartmill
Topics
Stocks
Eli Lilly Sells 53% More at Lower Prices: Rapid Earnings Reaction
↗
October 29, 2026
Eli Lilly’s realized prices fell 15%, but a 53% jump in volume pushed revenue up 39% and lifted full-year guidance by $5.5 billion. Here’s why the math works, and what could break it.
Via
The Motley Fool
S&P 500 Top Movers: Today's US Session Gainers and Losers
↗
October 29, 2026
Via
Chartmill
Topics
Stocks
S&P 500 Gap Movers: October 29, 2026 Session
↗
October 29, 2026
Via
Chartmill
Topics
Stocks
Eli Lilly (LLY) shares skyrocket, what you need to know
October 29, 2026
What happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 8.1% in the morning session after the company reported third-quarter 2026 ...
Via
StockStory
The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of Growth
October 29, 2026
Breakthroughs in obesity, diabetes, oncology, and targeted therapies are driving fresh interest in peptide-based medicines and the companies developing the next generation of treatments.
From
FN Media
Via
GlobeNewswire
The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of Growth
October 29, 2026
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:NVO),(NYSE:HIMS),(NYSE:ENHA),(NYSE:LLY) EQNX::TICKER_END
Via
FinancialNewsMedia
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today